CLINICAL_TRIALS
trial_result
· 2025-12-08
Clinical Trial Update: HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB) [Phase 2]
Summary
A Phase 2 trial of HepTcell immunotherapy in patients with inactive chronic hepatitis B was terminated, and results were posted on December 8, 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Altimmune, Inc. | Conditions: Hepatitis B, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2025-12-08